T Krause
Vitos Orthopedic Clinic Kassel(DE)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Microscopic Colitis, Eosinophilic Esophagitis, Biosimilars and Bioanalytical Methods, Immunodeficiency and Autoimmune Disorders
Most-Cited Works
- → Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis(2017)81 cited
- → DOP29 Pregnancy outcomes in IBD patients treated with vedolizumab, anti-TNF, or conventional therapy(2019)4 cited
- → P784 Real-world use and 6-month effectiveness of vedolizumab subcutaneous in IBD patients: results of the VEDO-IBD study(2023)2 cited
- → OP17 Maintenance phase propensity score adjusted effectiveness and persistence at week-52 in biologic-naïve Ulcerative Colitis patients treated with vedolizumab or anti-TNF (VEDO IBD-study)(2022)2 cited
- → P726 Effectiveness of vedolizumab therapy in a real-world setting in Germany: First results of the VEDOibd study comparing vedolizumab to the use of other biologics(2020)1 cited
- → PMH4 AN INDIRECT TREATMENT COMPARISON OF BREXPIPRAZOLE VERSUS LURASIDONE IN PATIENTS UNDERGOING ACUTE AND MAINTENANCE PHASE TREATMENT FOR SCHIZOPHRENIA(2019)1 cited
- → P742 Real-world evidence comparison on the effectiveness of ustekinumab vs anti-TNF or vedolizumab in ulcerative colitis: induction phase results from the prospective, observational RUN-UC study(2023)1 cited
- → OP36 Real-world evidence on comparative effectiveness of Ustekinumab vs anti-TNF in Crohn’s disease with propensity score adjustment: two-year maintenance phase results from the prospective observational RUN-CD study(2023)1 cited
- → DOP77 Comparative real-world effectiveness and persistence of vedolizumab versus anti-TNF therapy in biologic-naïve patients with Crohn′s Disease with Propensity Score adjustment: Maintenance phase results at week-52 from the prospective VEDOIBD study(2022)1 cited
- → DOP47 Real World Evidence on the effectiveness of ustekinumab in Crohn’s Disease: Induction phase results from the prospective, observational RUN-CD Study(2021)1 cited